Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on ASTELLAS PHARMA INC
06/24 ASTELLAS UK : Suspension from Membership of the ABPI to be Extended for 12 Month..
06/23 ASTELLAS PHARMA : president wants people to focus on lives saved by pharmaceutic..
06/22 ASTELLAS PHARMA : Drug company president wants people to focus on lives saved by..
06/21 ASTELLAS PHARMA : The Astellas Oncology C3 Prize Competition Returns for a Secon..
06/15 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/15 ASTELLAS PHARMA : White & Case Advises Ogeda Shareholders on Sale to Astellas Ph..
06/10 PFIZER : Astellas, Pfizer Announce Amendment to Clinical Research Protocol for P..
06/09 ASTELLAS PHARMA : Researchers Submit Patent Application, "Treatment Regimen Tiac..
06/09 ASTELLAS PHARMA : Patent Application Titled "Pharmaceutical Composition for Oral..
06/09 ASTELLAS PHARMA : New Data from Astellas Pharma Illuminate Findings in Type 2 Di..
06/09 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/08 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
06/05 ASTELLAS PHARMA : Kyoto University and Astellas Inaugurate "Alliance Station" wi..
06/01 ASTELLAS PHARMA : Data on Proinsulin Detailed by Researchers at Astellas Pharma ..
06/01 ASTELLAS PHARMA : Announces Commitments to GHIT Fund Replenishment
05/25 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
05/19 ASTELLAS PHARMA : MSD submits application for approval of type-2 diabetes drug c..
05/18 ASTELLAS PHARMA : Data on Pain Reported by Researchers at Astellas Pharma (Effec..
05/18 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/18 NANOSTRING TECHNOLOGIES, INC. (NASDA : NSTG) Files An 8-K Other Events
05/15 ASTELLAS PHARMA : Announces Continuation of Performance-linked Stock Compensatio..
05/12 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/11 ASTELLAS PHARMA : The Institute of Medical Science, the University of Tokyo, and..
05/01 TRANSFER OF 16 LONG-LISTED PRODUCTS : Closing of Asset Purchase Agreement
04/28 TRANSFER OF 16 LONG-LISTED PRODUCTS : Closing of Asset Purchase Agreement
04/27 ASTELLAS PHARMA : Researchers from Astellas Pharma Report New Studies and Findin..
04/27 ASTELLAS PHARMA : Researchers at Astellas Pharma Global Development Inc. Have Re..
04/27 ASTELLAS PHARMA : Researchers from Astellas Pharma Describe Findings in Pharmace..
04/27 ASTELLAS PHARMA : - Changes of Representative Directors and Directors
04/27 ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 266KB)
04/27 ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results (462 KB)
04/27 ASTELLAS PHARMA : Changes of Representative Directors and Directors (pdf 294KB)
04/27 ASTELLAS PHARMA : Announces Cancellation of Treasury Shares
04/27 ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results
04/20 ASTELLAS PHARMA : Recent Findings from Astellas Pharma Has Provided New Informat..
04/13 ASTELLAS PHARMA : to Acquire Ogeda SA
04/13 ASTELLAS PHARMA : Findings from Astellas Pharma Provides New Data about Pain (Th..
04/06 ASTELLAS PHARMA : Reports from Astellas Pharma Provide New Insights into Urothel..
04/06 ASTELLAS PHARMA : New Amino Acids Data Have Been Reported by Researchers at Aste..
04/06 ASTELLAS PHARMA : Reports Outline Rheumatoid Arthritis Study Findings from Astel..
04/03 ASTELLAS PHARMA : to acquire Belgian drug company in deal valued at as much as $..
04/03 ASTELLAS PHARMA : to acquire Belgium firm for up to 800 mil. euros
04/03 ASTELLAS PHARMA : To Buy Ogeda
04/03 ASTELLAS PHARMA : to Acquire Ogeda SA (pdf 306KB)
03/29 ASTELLAS PHARMA : Transfer of 16 Long-Listed Products in Japan
03/29 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/23 NEW CHROMATOGRAPHY STUDY FINDINGS HA : A Pitfall Associated...
03/23 ASTELLAS PHARMA : Findings from Astellas Pharma Provide New Insights into Urothe..
03/23 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
03/23 CYTOKINETICS : Announces Preclinical Data for CK-2127107 Presented at MDA Scient..
03/23 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 189KB)
03/22 ASTELLAS PHARMA : Launch of LINZESS® Tablets 0.25mg in Japan
03/16 ASTELLAS PHARMA : Researchers from Astellas Pharma Discuss Findings in Liver Can..
03/13 ASTELLAS PHARMA : Work begins on new pneumococcus vaccine
03/09 ASTELLAS PHARMA : Study Findings on Anemia Are Outlined in Reports from Astellas..
02/28 ASTELLAS PHARMA : and Affinivax Announce Worldwide Partnership for MAPS Vaccine ..
02/27 LUPIN : subsidiary Kyowa gets right to distribute quetiapine fumarate tablets in..
02/27 ASTELLAS PHARMA : Kyowa and Astellas enter into an Agreement for Exclusive Distr..
02/24 ASTELLAS PHARMA : Study Results from Astellas Pharma, Inc. Provide New Insights ..
02/23 ASTELLAS PHARMA : Joint Storage and Transportation of Pharmaceuticals in Hokkaid..
02/16 ASTELLAS PHARMA : Recent Findings from Astellas Pharma, Inc. Advance Knowledge i..
02/16 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Have Provided New Data on H..
02/16 ASTELLAS PHARMA : Researchers from Astellas Pharma, Inc. Report Recent Findings ..
02/16 ASTELLAS PHARMA : Reports from Astellas Pharma, Inc. Advance Knowledge in Antire..
02/16 ASTELLAS PHARMA : Recent Findings in Antifungals Described by Researchers from A..
02/09 ASTELLAS PHARMA : Details Findings in Immunoglobulins (Investigation of Hydrophi..
02/09 ASTELLAS PHARMA : and Ironwood Report Positive Top-Line Results from Phase III L..
02/09 ASTELLAS PHARMA : Announces Changes in Management tructure and lobal unction
02/09 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes
02/09 ASTELLAS PHARMA : Names Linda Friedman General Counsel for Worldwide Legal Organ..
02/08 ASTELLAS PHARMA : Announces Changes in Management Structure and Global Function ..
02/08 ASTELLAS PHARMA : Announces Personnel Changes and Organizational Changes (pdf 39..
02/02 ASTELLAS PHARMA : Improves Rank in Second Year Named to Corporate Knights' 2017 ..
02/02 ASTELLAS PHARMA : US Executive Interview Series - Dr. David Stover
02/01 ASTELLAS PHARMA : Announces Acquisition of Own Shares
Advertisement
Financials ( JPY)
Sales 2018 1 291 531 M
EBIT 2018 260 000 M
Net income 2018 200 482 M
Finance 2018 448 301 M
Yield 2018 2,54%
P/E ratio 2018 14,49
P/E ratio 2019 14,82
EV / Sales 2018 1,90x
EV / Sales 2019 1,84x
Capitalization 2 906 697 M
More Financials
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Full-screen chart
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Average target price 1 513  JPY
Spread / Average Target 7,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Yasumasa Masuda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
Hironobu Yasuda Outside Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-13.59%26 111
JOHNSON & JOHNSON18.42%367 520
NOVARTIS12.96%225 386
ROCHE HOLDING LTD.8.68%224 497
PFIZER5.20%203 487
MERCK AND COMPANY12.38%180 958
More Results